ASX - By Stock
|
PIQ |
Re:
PIQ $1.00
|
|
JujuM
|
106 |
36K |
7 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
106
|
36K
|
7
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: PromarkerD US commercialisation & Promarker pipeline update
|
|
JujuM
|
63 |
20K |
4 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
63
|
20K
|
4
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics signs with Oxford Univ to validate test for Endo
|
|
JujuM
|
4 |
1.7K |
2 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
4
|
1.7K
|
2
|
|
ASX - By Stock
|
PIQ |
Re:
PIQ $1.00
|
|
JujuM
|
106 |
36K |
0 |
23/03/24 |
23/03/24 |
ASX - By Stock
|
106
|
36K
|
0
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: PromarkerD US commercialisation & Promarker pipeline update
|
|
JujuM
|
63 |
20K |
1 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
63
|
20K
|
1
|
|
ASX - By Stock
|
PIQ |
Re:
PIQ $1.00
|
|
JujuM
|
106 |
36K |
1 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
106
|
36K
|
1
|
|
ASX - By Stock
|
PIQ |
Re:
PIQ $1.00
|
|
JujuM
|
106 |
36K |
1 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
106
|
36K
|
1
|
|
ASX - By Stock
|
PIQ |
Re:
PIQ $1.00
|
|
JujuM
|
106 |
36K |
1 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
106
|
36K
|
1
|
|
ASX - By Stock
|
PIQ |
Re:
PIQ: IPO update
|
|
JujuM
|
37 |
13K |
3 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
37
|
13K
|
3
|
|
ASX - By Stock
|
PIQ |
Re:
Value Projections
|
|
JujuM
|
41 |
12K |
1 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
41
|
12K
|
1
|
|
ASX - By Stock
|
PIQ |
Re:
Value Projections
|
|
JujuM
|
41 |
12K |
8 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
41
|
12K
|
8
|
|
ASX - By Stock
|
PIQ |
Re:
Value Projections
|
|
JujuM
|
41 |
12K |
5 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
41
|
12K
|
5
|
|
ASX - By Stock
|
PIQ |
Re:
Value Projections
|
|
JujuM
|
41 |
12K |
3 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
41
|
12K
|
3
|
|
ASX - By Stock
|
PIQ |
Re:
Value Projections
|
|
JujuM
|
41 |
12K |
9 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
41
|
12K
|
9
|
|
ASX - By Stock
|
PIQ |
Re:
PIQ $1.00
|
|
JujuM
|
106 |
36K |
6 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
106
|
36K
|
6
|
|
ASX - By Stock
|
PIQ |
Re:
PIQ $1.00
|
|
JujuM
|
106 |
36K |
4 |
03/03/24 |
03/03/24 |
ASX - By Stock
|
106
|
36K
|
4
|
|
ASX - By Stock
|
PIQ |
Re:
PIQ $1.00
|
|
JujuM
|
106 |
36K |
5 |
02/03/24 |
02/03/24 |
ASX - By Stock
|
106
|
36K
|
5
|
|
ASX - By Stock
|
PIQ |
Re:
PIQ $1.00
|
|
JujuM
|
106 |
36K |
1 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
106
|
36K
|
1
|
|
ASX - By Stock
|
PIQ |
Re:
PIQ $1.00
|
|
JujuM
|
106 |
36K |
6 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
106
|
36K
|
6
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: European patent granted for OxiDx technology
|
|
JujuM
|
4 |
1.4K |
3 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
4
|
1.4K
|
3
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: European patent granted for OxiDx technology
|
|
JujuM
|
4 |
1.4K |
5 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
4
|
1.4K
|
5
|
|
ASX - By Stock
|
PIQ |
Re:
PIQ $1.00
|
|
JujuM
|
106 |
36K |
6 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
106
|
36K
|
6
|
|
ASX - By Stock
|
PIQ |
Re:
PIQ $1.00
|
|
JujuM
|
106 |
36K |
7 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
106
|
36K
|
7
|
|
ASX - By Stock
|
PIQ |
Re:
PIQ $1.00
|
|
JujuM
|
106 |
36K |
2 |
17/02/24 |
17/02/24 |
ASX - By Stock
|
106
|
36K
|
2
|
|
ASX - By Stock
|
PIQ |
Re:
PIQ $1.00
|
|
JujuM
|
106 |
36K |
4 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
106
|
36K
|
4
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Becoming a substantial holder
|
|
JujuM
|
11 |
5.1K |
10 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
11
|
5.1K
|
10
|
|
ASX - By Stock
|
PIQ |
Re:
PIQ $1.00
|
|
JujuM
|
106 |
36K |
6 |
29/01/24 |
29/01/24 |
ASX - By Stock
|
106
|
36K
|
6
|
|
ASX - By Stock
|
PIQ |
Re:
PIQ $1.00
|
|
JujuM
|
106 |
36K |
13 |
29/01/24 |
29/01/24 |
ASX - By Stock
|
106
|
36K
|
13
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics to raise $6.5m through Institutional Placement
|
|
JujuM
|
31 |
9.4K |
4 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
31
|
9.4K
|
4
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Investor Presentation
|
|
JujuM
|
3 |
1.0K |
2 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
3
|
1.0K
|
2
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics to raise $6.5m through Institutional Placement
|
|
JujuM
|
31 |
9.4K |
5 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
31
|
9.4K
|
5
|
|
ASX - By Stock
|
PIQ |
Re:
PIQ $1.00
|
|
JujuM
|
106 |
36K |
4 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
106
|
36K
|
4
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics to raise $6.5m through Institutional Placement
|
|
JujuM
|
31 |
9.4K |
1 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
31
|
9.4K
|
1
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics to raise $6.5m through Institutional Placement
|
|
JujuM
|
31 |
9.4K |
0 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
31
|
9.4K
|
0
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics to raise $6.5m through Institutional Placement
|
|
JujuM
|
31 |
9.4K |
12 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
31
|
9.4K
|
12
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: AGM Chairman's Address and Investor Presentation
|
|
JujuM
|
75 |
22K |
5 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
75
|
22K
|
5
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: AGM Chairman's Address and Investor Presentation
|
|
JujuM
|
75 |
22K |
5 |
03/01/24 |
03/01/24 |
ASX - By Stock
|
75
|
22K
|
5
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: AGM Chairman's Address and Investor Presentation
|
|
JujuM
|
75 |
22K |
7 |
02/01/24 |
02/01/24 |
ASX - By Stock
|
75
|
22K
|
7
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: PromarkerD licence with Omics Global extended to Chile
|
|
JujuM
|
2 |
907 |
9 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
2
|
907
|
9
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: AGM Chairman's Address and Investor Presentation
|
|
JujuM
|
75 |
22K |
7 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
75
|
22K
|
7
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: US Medicare confirms reimbursement price for PromarkerD
|
|
JujuM
|
14 |
3.6K |
11 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
14
|
3.6K
|
11
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Sonic Healthcare USA signs licence for PromarkerD in the US
|
|
JujuM
|
78 |
34K |
0 |
20/10/23 |
20/10/23 |
ASX - By Stock
|
78
|
34K
|
0
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Sonic Healthcare USA signs licence for PromarkerD in the US
|
|
JujuM
|
78 |
34K |
4 |
07/10/23 |
07/10/23 |
ASX - By Stock
|
78
|
34K
|
4
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: PromarkerD US reimbursement price & Aus regulatory decision
|
|
JujuM
|
17 |
7.5K |
15 |
29/09/23 |
29/09/23 |
ASX - By Stock
|
17
|
7.5K
|
15
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Request for extension of voluntary suspension
|
|
JujuM
|
13 |
4.8K |
2 |
25/09/23 |
25/09/23 |
ASX - By Stock
|
13
|
4.8K
|
2
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Request for extension of voluntary suspension
|
|
JujuM
|
13 |
4.8K |
0 |
25/09/23 |
25/09/23 |
ASX - By Stock
|
13
|
4.8K
|
0
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Request for extension of voluntary suspension
|
|
JujuM
|
12 |
4.3K |
3 |
22/09/23 |
22/09/23 |
ASX - By Stock
|
12
|
4.3K
|
3
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Request for extension of voluntary suspension
|
|
JujuM
|
12 |
4.3K |
7 |
22/09/23 |
22/09/23 |
ASX - By Stock
|
12
|
4.3K
|
7
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Suspension from Quotation
|
|
JujuM
|
5 |
2.8K |
10 |
20/09/23 |
20/09/23 |
ASX - By Stock
|
5
|
2.8K
|
10
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Suspension from Quotation
|
|
JujuM
|
5 |
2.8K |
4 |
18/09/23 |
18/09/23 |
ASX - By Stock
|
5
|
2.8K
|
4
|
|